Finance
Markets
No recent trading data. The last price we hold for WST is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

WST

stock
West Pharmaceutical Services
$316.31 +4.14 (+1.33%) Delayed · quoted 47d ago
Healthy 61% Climbing

What the indicators say

Bullish 5 of 5 trend signals bullish
Momentum · RSI 14 Leaning bullish
59
0oversold 30overbought 70100

RSI 59 — firm momentum, not yet overbought.

EMA 21 $309.71
Above
Near-term trend is up
SMA 50 $288.57
Above
Medium-term trend is up
SMA 200 $267.21
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $297.30
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $309.88 High $317.56
Open
$316.31
+1.33%
Close
$316.31
+1.33%
52-week range where the price sits across its year
52w low $206.19 52w high $330.88
Current
$316.31
Prev close
$312.17
Volume 0.58× the 3-month average
0 avg 2× avg
Today
509.78K
3-mo avg
880.27K

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2389 days ago
Next expected
Jul 23in 2 days

Recent earnings dates

  • Apr 23 89 days ago
  • Feb 12 159 days ago
  • Oct 23, 2025 271 days ago
  • Jul 24, 2025 362 days ago

Past earnings dates come from WST’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), WST’s fundamentals read as strong overall.

P/E ratio Weak
42.3x

At 42.3x, the price is steep relative to profit; the stock leans heavily on growth that has yet to arrive.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.27%

A 0.3% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
16.1%

A 16.1% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
15.5%

A 15.5% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
11.6%

A 11.6% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.34

At 0.34, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
3.02

At 3.02, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+6.3%

Revenue grew 6.3% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+0.2%

Net income grew 0.2% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $2.8B$2.9B$2.9B$2.9B$3.1B
Net income $661.8M$585.9M$593.4M$492.7M$493.7M
Diluted EPS $8.67$7.73$7.88$6.69$6.79
Dividend / share $0.70$0.74$0.78$0.82$0.86
Total assets $3.3B$3.6B$3.8B$3.6B$4.3B
Total liabilities $978.4M$931.9M$948.5M$961.1M$1.1B
Shareholder equity $2.3B$2.7B$2.9B$2.7B$3.2B

Leadershipsynced from SEC 52d ago

  • Campbell Shane Alden SVP, Proprietary Segment
  • Feehery William F Director
  • Friel Robert F Director
  • Haugen Janet Brutschea Director
  • Joseph Molly Director
  • Keller Deborah L Director
  • Lai Goldman Myla Director
  • Lockhart Stephen H Director
  • Michels Douglas A Director
  • Pucci Paolo Director

Officers and board are drawn from WST’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$0.85
2026 so far
$0.442 payments
2026 projected
$0.88+3.5% vs 2025

Projection scales WST’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Apr 29 $0.22
  • Jan 28 $0.22
  • Nov 12, 2025 $0.22
  • Jul 30, 2025 $0.21
  • Apr 30, 2025 $0.21
  • Feb 7, 2025 $0.21
  • Nov 13, 2024 $0.21
  • Jul 31, 2024 $0.20
  • Apr 23, 2024 $0.20
  • Jan 30, 2024 $0.20
  • Nov 7, 2023 $0.20
  • Jul 25, 2023 $0.19
  • Apr 25, 2023 $0.19
  • Jan 24, 2023 $0.19
  • Nov 8, 2022 $0.19
  • Jul 19, 2022 $0.18
  • Apr 19, 2022 $0.18
  • Jan 18, 2022 $0.18
  • Nov 9, 2021 $0.18
  • Jul 20, 2021 $0.17

Recent SEC filingssynced from SEC 51d ago

© 2026 Isaac Bythewood · Some rights reserved